Roper Technologies, Inc. · ROP · FY2026 Q3 · Calendar Q4 2026
Roper raises DEPS outlook as AI adoption expands across portfolio
Roper's current evidence supports a constructive but conditional growth thesis: resilient software demand, expanding AI offerings, cloud migration, and bolt-on acquisitions are supporting growth, while monetization, execution, Neptune's mix, and freight demand remain unresolved.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about ROP FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The company reported 8% Q3 revenue growth and 15% adjusted DEPS growth, raised full-year adjusted DEPS guidance, expanded AI activity across its portfolio, and deployed $436 million on three bolt-on acquisitions. Neptune's mechanical-meter mix emerged as a current margin headwind, while management characterized the effect as temporary.
Guidance delta
Management raised full-year adjusted DEPS guidance to $22.35-$22.40 while maintaining revenue growth expectations north of 8%.
Key takeaways
- Q3 revenue rose 8% year over year to $2.2 billion, while adjusted DEPS increased 15% to $5.89.
- AI-enabled offerings now span 17-18 of 21 businesses, with early AI-related bookings highlighted at CentralReach, Aderant, and Vertafore.
- The company deployed $436 million across three bolt-on acquisitions and retains capacity for additional deals.
- Neptune's lower-margin mechanical-meter mix pressured results; management expects the mix to normalize next year.
- The growth case rests on AI monetization, cloud migration, acquisitions, and a recovery in freight volumes.
Management priorities
- Scale AI product development and go-to-market execution across vertical software businesses.
- Accelerate cloud conversions for legacy on-premise applications, especially Deltek.
- Pursue bolt-on acquisitions within core verticals while preserving capital-allocation flexibility.
- Use the AI accelerator team to share tooling and models across businesses.
- Support continued adoption of AI-enabled products and monitor Neptune's meter mix.
Follow ROP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 18, 2026 |
| Argus Research | Buy | Hold | Upgrade | Aug 6, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jul 29, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 29, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jan 28, 2026 |
| Stifel | Hold | Buy | Downgrade | Jan 28, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jan 28, 2026 |
| Mizuho | Underperform | Underperform | Maintain | Jan 28, 2026 |
| Citigroup | Buy | Buy | Maintain | Jan 28, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 5, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 24, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 24, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 13, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Jan 22, 2024 |
| Bernstein | Outperform | Market Perform | Upgrade | May 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 26, 2022 |
| Stephens & Co. | Overweight | Overweight | Maintain | Apr 30, 2019 |
| Argus | Buy | Buy | Maintain | Aug 2, 2018 |
| Canaccord Genuity | Hold | Hold | Maintain | Feb 5, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 2, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $436.23. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $450 | $394.53 | +3.2% | Aug 6, 2026 |
| RBC Capital | Deane Dray | $417 | $370.27 | -4.4% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $480 | $355.12 | +10.0% | Jul 24, 2026 |
| Piper Sandler | Clarke Jeffries | $526 | $355.12 | +20.6% | Jul 24, 2026 |
| Mizuho Securities | Analyst unavailable | $355 | $362.84 | -18.6% | Jul 21, 2026 |
| BMO Capital | Daniel Jester | $393 | $355.94 | -9.9% | Jul 10, 2026 |
| RBC Capital | Analyst unavailable | $407 | $363.76 | -6.7% | Apr 24, 2026 |
| Robert W. Baird | Analyst unavailable | $470 | $363.76 | +7.7% | Apr 24, 2026 |
| Piper Sandler | Analyst unavailable | $540 | $363.76 | +23.8% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $373 | $363.76 | -14.5% | Apr 24, 2026 |
| Goldman Sachs | Analyst unavailable | $440 | $360.37 | +0.9% | Jan 29, 2026 |
| RBC Capital | Analyst unavailable | $398 | $360.66 | -8.8% | Jan 28, 2026 |
| Mizuho Securities | Analyst unavailable | $365 | $360.98 | -16.3% | Jan 28, 2026 |
| Robert W. Baird | Analyst unavailable | $550 | $358.34 | +26.1% | Jan 28, 2026 |
| Jefferies | Analyst unavailable | $500 | $369.27 | +14.6% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $409 | $369.27 | -6.2% | Jan 28, 2026 |
| Stifel Nicolaus | Analyst unavailable | $385 | $369.27 | -11.7% | Jan 27, 2026 |
| Truist Financial | Terry Tillman | $550 | $369.27 | +26.1% | Jan 27, 2026 |
| Melius Research | Scott Davis | $479 | $355.89 | +9.8% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $525 | $407.48 | +20.3% | Jan 23, 2026 |
| Piper Sandler | Clarke Jeffries | $530 | $432.39 | +21.5% | Jan 13, 2026 |
| Jefferies | Analyst unavailable | $600 | $430.77 | +37.5% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $419 | $434.54 | -3.9% | Jan 5, 2026 |
| Barclays | Analyst unavailable | $475 | $445.89 | +8.9% | Dec 4, 2025 |
| Piper Sandler | Clarke Jeffries | $600 | $444.78 | +37.5% | Nov 19, 2025 |
| Barclays | Analyst unavailable | $506 | $470.18 | +16.0% | Oct 27, 2025 |
| RBC Capital | Analyst unavailable | $539 | $478.8 | +23.6% | Oct 27, 2025 |
| Truist Financial | Analyst unavailable | $650 | $479.85 | +49.0% | Oct 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $550 | $479.96 | +26.1% | Oct 24, 2025 |
| RBC Capital | Deane Dray | $644 | $479.96 | +47.6% | Oct 24, 2025 |
| Robert W. Baird | Analyst unavailable | $592 | $479.96 | +35.7% | Oct 24, 2025 |
| Raymond James | Brian Gesuale | $575 | $479.51 | +31.8% | Oct 24, 2025 |
| Jefferies | Analyst unavailable | $650 | $479.96 | +49.0% | Oct 23, 2025 |
| Oppenheimer | Ken Wong | $570 | $479.96 | +30.7% | Oct 23, 2025 |
| Mizuho Securities | Brett Linzey | $510 | $500.08 | +16.9% | Oct 17, 2025 |
| Barclays | Julian Mitchell | $550 | $498.69 | +26.1% | Oct 1, 2025 |
| Mizuho Securities | Brett Linzey | $600 | $582.88 | +37.5% | May 16, 2025 |
| Oppenheimer | Christopher Glynn | $640 | $557.7 | +46.7% | Apr 28, 2025 |
| Stifel Nicolaus | Analyst unavailable | $685 | $582.71 | +57.0% | Mar 26, 2025 |
| Robert W. Baird | Joe Vruwink | $665 | $575.65 | +52.4% | Jan 31, 2025 |
| Truist Financial | Terry Tillman | $665 | $542.94 | +52.4% | Oct 24, 2024 |
| Robert W. Baird | Richard Eastman | $652 | $542.94 | +49.5% | Oct 24, 2024 |
| RBC Capital | Deane Dray | $666 | $542.94 | +52.7% | Oct 24, 2024 |
| Robert W. Baird | Joe Vruwink | $635 | $531.97 | +45.6% | Jul 25, 2024 |
| Barclays | Julian Mitchell | $625 | $550.47 | +43.3% | Jul 10, 2024 |
| Argus Research | John Eade | $575 | $511.46 | +31.8% | Apr 30, 2024 |
| Wolfe Research | Brad Hewitt | $625 | $543.01 | +43.3% | Apr 8, 2024 |
| Oppenheimer | Christopher Glynn | $650 | $556.38 | +49.0% | Mar 22, 2024 |
| Goldman Sachs | Analyst unavailable | $468 | $429.25 | +7.3% | Dec 15, 2022 |
| RBC Capital | Analyst unavailable | $565 | $472.01 | +29.5% | Apr 27, 2022 |
| Cowen & Co. | Joseph C Giordano | $520 | $487.88 | +19.2% | Jul 26, 2021 |
| Oppenheimer | Christopher Glynn | $560 | $494.71 | +28.4% | Jul 23, 2021 |
Track every rating change on ROP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRoper Technologies, Inc., established in 1981 and based in Sarasota, Florida (formerly known as Roper Industries, Inc. until 2015), operates as a diversified technology company. It specializes in developing and delivering advanced software solutions alongside highly engineered products for a wide range of industries. Its extensive software portfolio includes enterprise and financial management systems, cloud-based analytics for sectors like insurance and healthcare, campus and supply chain management tools, and specialized applications for areas such as foodservice, visual effects, and data collaboration. Complementing this, Roper designs and manufactures a diverse array of engineered products, encompassing precision testing instruments for materials like rubber and plastic, medical devices (such as ultrasound accessories), flow and control components (including valves, pumps, and meters), automated dispensing and monitoring equipment (like leak detection and vibration monitoring systems), and various sensors for industrial and utility applications.
Historical context
All ROP earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SSNC SS&C Technologies Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +2.8% | SS&C raises 2026 outlook as AI and tokenization drive growth |
| VRSN VeriSign, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -0.9% | VeriSign sustains domain growth as .web and security launches near |
| TTMI TTM Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -27.2% | TTM Technologies: Record Q3, but execution risks remain |
| NOK Nokia Oyj | FY2026 Q3 · Calendar Q4 2026 | — | -12.4% | Nokia Q3: AI and Cloud Growth Lift Margins, Cash Flow Lags |
| CACI CACI International Inc | FY2027 Q1 · Calendar Q4 2026 | +16.6% | -1.5% | CACI raises FY27 outlook as backlog and defense awards expand |
| TXN Texas Instruments Incorporated | FY2026 Q3 · Calendar Q4 2026 | +7.4% | +2.5% | Texas Instruments Q3: Strong Demand, Higher Capex and Lead-Time Risks |
Latest beats and misses
Who reports nextBeat on EPS
- MEDPFY2026 Q3 · October 21, 2026+9.0% EPS-1.3% move
- MOHFY2026 Q3 · October 21, 2026+12.7% EPS+0.8% move
- PNFPFY2026 Q3 · October 21, 2026+2.7% EPS+2.3% move
- SCCOFY2026 Q3 · October 21, 2026+6.4% EPS-2.1% move
- PKGFY2026 Q3 · October 21, 2026+3.8% EPS+4.2% move
- URIFY2026 Q3 · October 21, 2026+11.3% EPS+3.9% move
Missed on EPS
- ROLFY2026 Q3 · October 21, 2026-1.4% EPS+5.6% move
- GGGFY2026 Q3 · October 21, 2026-2.5% EPS-16.6% move
- GL-PDFY2026 Q3 · October 21, 2026-1.2% EPS— move
- GLFY2026 Q3 · October 21, 2026-1.2% EPS-3.8% move
- METAFY2026 Q3 · October 21, 2026-41.4% EPS+0.5% move
- LVSFY2026 Q3 · October 21, 2026-20.9% EPS-1.7% move
Get the ROP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-22T17:05:05.742528+00:00
- FN2 earnings calendar · 2026-10-22T01:23:13.354406+00:00
- Polygon adjusted daily market bars · 2026-10-22T23:00:42.842619+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-22T23:00:42.839908+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-22. For educational purposes only; not investment advice.